IL6 and metabolic dysfunction-associated steatotic liver disease: Furthermore, acetate engaged G protein-coupled receptor 43 (GPR43) on hepatocytes, inhibiting the IL-6/JAK1/STAT3 pathway, inducing apoptosis of NAFLD/HCC tumor cells, preventing tumor formation, and enhancing intestinal barrier function (Song et al., 2023).